Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Stock Quote Today & Recent News Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Bullboard Posts (CSE:AGN)

Today’s Trading

The trend is now well established.  Integral is nowhere on the CSE Depth Display and the mini trades, $75 to $150, all involvie...
nodaytrader - 5 hours ago

Today’s Trading

Down from 9 cents to 7.5 cents today with a total 12 trades so far. All mini trades - the largest being $300 - and all involving National...
nodaytrader - 6 days ago

Trading Update

Price now down to 8 cents. 10 trades so far today. First 5 involve National Bank followed by 5 involving Desjardins.    
nodaytrader - 7 days ago

Todo Trading

Great news from Algernon last week and today, suddenly, we have four trades only, all involving National Bank,that drop the price by a...
nodaytrader - 7 days ago

Microcap penny stock up big on asset sale

https://stockhouse.com/news/the-market-herald-news/2023/11/22/microcap-penny-stock-up-big-on-asset-sale
TrevorAbes - 12 days ago

Algernon announces acquisition of chronic cough program

So what's the real story here? Program acquired by US based Seylyx Inc. they have a barebone website and the domain was registered...
Whalewatcher1 - 12 days ago

Connect with C.AGN


CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Download the Presentaion

Facebook